Effect of Curcumin in Treatment of Pediatric Intractable Epilepsy

Phase 3

• Conditions: Pediatric intractable epilepsy.; Epilepsy, unspecified, intractable, without status epilepticus; G40.919

• Registration Number: IRCT20130811014330N7
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 22

Inclusion Criteria

Have at least 4 epileptic seizures in the last 4 weeks.
Has been using anticonvulsant drugs for at least the last 1 month.
The child's parents have informed consent.
Not having a history of exacerbating seizures.
Not having a cardiovascular, liver, or kidney disorder.

Exclusion Criteria

Diagnosing a curable cause for the epilepsy.
Epilepsy is secondary to a progressive or neurodegenerative brain disorder.
Having a history of status epilepsy within the past 3 months.
Having multiple and uncountable seizures.
Lack of cooperation in taking the medicines properly.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of seizure attacks. Timepoint: baseline (before starting intervention), 4, 6,10 weeks after intervention. Method of measurement: based on clinical report of attacks.

Secondary Outcome Measures

Name	Time	Method
. Timepoint: . Method of measurement: .